# US 12,109,150 B2 · Ophthalmic treatment device, method for controlling ophthalmic treatment device, and fundus lesion treatment method > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 12,109,150 B2 - Document ID: US12109150B2 - Status: Granted - Kind: B2 - Application number: 17/850,987 - Filed: 2022-06-27 - Published: 2022-10-13 - Granted: 2024-10-08 - Earliest claimed: 2013-12-09 - Assignees: Lutronic Vision Inc. - Applicants: Lutronic Vision Inc. - Inventors: Jong Min Kim - Web page: https://patentgrep.com/patent/US12109150B2 ## CPC - A61F 9/008: using laser - A61F 2009/00863: {Retina} - A61F 2009/00897: {Scanning mechanisms or algorithms} - A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C) ## Abstract The present invention relates to an ophthalmic treatment device, a control method therefor and a fundus lesion treatment method, the ophthalmic treatment device comprising: a treatment beam generation unit for generating a treatment beam; a beam delivery unit for forming a path through which the treatment beam generated from the treatment beam generating unit is irradiated into a patient's fundus; and a control unit for controlling the beam delivery unit to irradiate the treatment beam into a location adjacent to the lesion area of the fundus. ## Claims ### Claim 1 A treatment device, comprising: a treatment beam generation unit generating a treatment beam; a beam delivery unit delivering the treatment beam generated in the treatment beam generation unit to a patient's treatment area; and a controller controlling at least one of the treatment beam generation unit and a beam delivery unit to radiate the treatment beam to one or more locations adjacent to a lesion area of the treatment area without radiating the treatment beam to the lesion area, the one or more locations being outside the lesion area and separated from a boundary of the lesion area so as to prevent the lesion area from expanding. ### Claim 2 (depends on 1) The treatment device of claim 1, wherein the one or more locations are separated by a predetermined gap or more from the boundary of the lesion area. ### Claim 3 (depends on 1) The treatment device of claim 1, wherein the lesion area is any one of an area in which geography angiography has occurred, an area in which drugen is formed, an area in which blood leakage has occurred, and an area in which macular edema is formed. ### Claim 4 (depends on 1) The treatment device of claim 1, wherein the treatment device is for treating ophthalmic disease and the treatment area is located in a patient's fundus. ### Claim 5 (depends on 4) The treatment device of claim 4, wherein the controller controls to radiate the treatment beam along a pattern that partitions between the lesion area and a center of the fundus. ### Claim 6 (depends on 4) The treatment device of claim 4, wherein the treatment beam transfers energy to a depth in which an RPE cell layer is located at a patient's fundus. ### Claim 7 (depends on 4) The treatment device of claim 4, wherein the controller controls to radiate the treatment beam to the one or more locations that are separated by at least one RPE cell size from the boundary of the lesion area. ### Claim 8 (depends on 1) The treatment device of claim 1, wherein the controller controls to radiate the treatment beam in a pattern separated by 10 μm or more from the boundary of the lesion area. ### Claim 9 (depends on 1) The treatment device of claim 1, wherein the controller controls to radiate the treatment beam in a pattern separated by 10-200 μm from the boundary of the lesion area. ### Claim 10 (depends on 1) The treatment device of claim 1, wherein a pattern of the treatment beam encloses the lesion area. ### Claim 11 (depends on 10) The treatment device of claim 10, wherein the pattern of the treatment beam forms a closed curve that encloses the lesion area. ### Claim 12 (depends on 1) The treatment device of claim 1, wherein a pattern of the treatment beam encompasses at least a part of the lesion area. ### Claim 13 (depends on 1) The treatment device of claim 1, wherein the controller controls to radiate the treatment beam to form a first pattern and a second pattern, the first pattern is located outside the lesion area and separated from the boundary of the lesion area, and the second pattern is located further than the first pattern from the boundary of the lesion area. ### Claim 14 (depends on 13) The treatment device of claim 13, wherein a radiation gap of a treatment beam constituting the first pattern is smaller than that of a treatment beam constituting the second pattern. ### Claim 15 (depends on 1) The treatment device of claim 1, wherein the treatment beam includes a plurality of beams, and the controller controls to sequentially radiate the plurality of beams at the same location and controls a parameter of the treatment beam, and wherein the parameter of the treatment beam is any one of an output, a beam size, and a pulse pattern of the treatment beam. ### Claim 16 A method of treating a lesion of a patient, the method comprising: determining a lesion area using an image of a treatment area comprising the lesion; radiating a treatment beam to a plurality of locations adjacent to a boundary of the lesion area so as to prevent the lesion area from expanding, wherein the radiating of the treatment beam comprises radiating the treatment beam at the plurality of locations being outside the lesion area and separated from the boundary of the lesion area without radiating the treatment beam to the lesion area. ### Claim 17 (depends on 16) The method of claim 16, wherein the one or more locations are separated by a predetermined gap or more from the boundary of the lesion area. ### Claim 18 (depends on 16) The method of claim 16, wherein the lesion area is any one of an area in which geography angiography has occurred, an area in which drugen is formed, an area in which blood leakage has occurred, and an area in which macular edema is formed. ### Claim 19 (depends on 16) The method of claim 16, wherein the method of treating the lesion is for treating ophthalmic disease and the treatment area is located in a patient's fundus. ### Claim 20 (depends on 1) The treatment device of claim 1, wherein the treatment beam has a wavelength selectively absorbed into an RPE cell layer in a retina tissue, and the wavelength of the treatment beam is in a range of 500 nm-600 nm or 800 nm-900 nm.